3. May 2022
Read the Latest News
or Download our Publications.
27. April 2022
Securing international patents for mass-produced graphene biosensors
Today, Cardea Bio, Inc. - the world's first mass producer of graphene biosensors - shares their...
5. April 2022
Cardea Bio completes planned launch of CRISPR QC
San Diego, CA -- April 5, 2022 -- Today, Cardea Bio, Inc. - the world’s only mass producer of...
8. March 2022
Nature Awards Webcasts: Kiana Aran and the future of CRISPR technology
An exciting and inspiring session with our Chief Scientific Officer, Kiana Aran, on the future of...
2. February 2022
Dr. Kiana Aran Receives NIH Funding to Help Set Quality Control Standards for CRISPR Therapies
Dr. Kiana Aran, Associate Professor of Medical Diagnostics and Therapeutics and head of the Aran...
10. January 2022
Cardea announces a collaboration agreement with Siemens Healthineers to assess feasibility of real-time applications
San Diego, CA -- January 10, 2022 -- Today, Cardea Bio, Inc. - the world’s only mass producer of...
9. December 2021
Cardea Bio accelerates commercial platform due to demand from market moving partners
To signal that Cardea Bio, Inc. is investing significantly into the commercialization efforts of...
1. December 2021
Cardea SNP Chip Named Top 10 Innovation of 2021 by The Scientist
The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing...
28. October 2021
Dr. Kiana Aran wins the 2021 Nature Research Award for Scientific Achievement
October 28, 2021 12:00 PM Eastern Daylight Time LONDON & SAN DIEGO--(BUSINESS WIRE)--Nature, a...
12. October 2021